We are live on ! Find out more
DA

Dunvegan Associates Portfolio holdings

AUM $85.1M
1-Year Est. Return 2.3%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
-2.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$85.1M
AUM Growth
-$2.61M
Cap. Flow
-$3.87M
Cap. Flow %
-4.55%
Top 10 Hldgs %
52.45%
Holding
212
New
3
Increased
9
Reduced
63
Closed
8

Top Sells

Rank Stock Value
1
ENB icon
Enbridge
ENB
+$1.07M
2
TRP icon
TC Energy
TRP
+$877K
3
DVN icon
Devon Energy
DVN
+$540K
4
D icon
Dominion Energy
D
+$480K
5
AMLP icon
Alerian MLP ETF
AMLP
+$367K

Sector Composition

Rank Sector Weight
1 Miscellaneous 18.81%
2 Financials 18.27%
3 Healthcare 16.04%
4 Consumer Staples 13.36%
5 Energy 11.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MA icon
1
Mastercard
MA
$521B
$9.54M 11.21%
97,966
-1,948
-2% -$191K
MKC icon
2
McCormick & Company Non-Voting
MKC
$14.9B
$6.77M 7.96%
158,276
+2,648
+2% +$112K
V icon
3
Visa
V
$712B
$5.64M 6.63%
72,776
-941
-1% -$72.9K
LNG icon
4
Cheniere Energy
LNG
$58.3B
$3.88M 4.57%
104,283
-3,948
-4% -$180K
LLY icon
5
Eli Lilly
LLY
$1.05T
$3.49M 4.1%
41,378
-423
-1% -$35.1K
GLD icon
6
SPDR Gold Trust
GLD
$149B
$3.45M 4.05%
33,996
-879
-3% -$92.9K
XLP icon
7
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$3.37M 3.96%
66,749
-1,133
-2% -$56.3K
NVS icon
8
Novartis
NVS
$292B
$3.15M 3.7%
40,876
-374
-0.9% -$29.7K
ACN icon
9
Accenture
ACN
$116B
$2.71M 3.19%
25,940
-553
-2% -$58.4K
AGN
10
DELISTED
Allergan plc
AGN
$2.63M 3.09%
8,407
-152
-2% -$45.3K
UPS icon
11
United Parcel Service
UPS
$89.6B
$2.09M 2.46%
21,718
-318
-1% -$32.5K
WPZ
12
DELISTED
Williams Partners L.P.
WPZ
$2.03M 2.39%
72,905
-2,628
-3% -$78.9K
IBB icon
13
iShares Biotechnology ETF
IBB
$10.5B
$1.75M 2.05%
15,471
-1,038
-6% -$113K
STZ icon
14
Constellation Brands
STZ
$22.3B
$1.67M 1.96%
11,741
-185
-2% -$25.5K
MDT icon
15
Medtronic
MDT
$117B
$1.53M 1.8%
19,879
-425
-2% -$32K
NVO
16
Novo Nordisk
NVO
$202B
$1.47M 1.72%
50,454
-1,100
-2% -$30.4K
MMM icon
17
3M
MMM
$89.9B
$1.42M 1.67%
11,277
-275
-2% -$35.3K
EWY icon
18
iShares MSCI South Korea ETF
EWY
$28B
$1.35M 1.59%
27,273
-2,002
-7% -$105K
TIF
19
DELISTED
Tiffany & Co.
TIF
$1.19M 1.4%
15,646
-1,196
-7% -$93.4K
UNP icon
20
Union Pacific
UNP
$183B
$1.16M 1.36%
14,788
-1,381
-9% -$118K
TEF
21
DELISTED
Telefonica
TEF
$1.15M 1.35%
134,077
-10,454
-7% -$99K
EWI icon
22
iShares MSCI Italy ETF
EWI
$1.12B
$1.12M 1.32%
40,837
-196
-0.5% -$5.67K
TTM
23
DELISTED
Tata Motors Limited
TTM
$1.08M 1.26%
+36,512
New +$1.06M
EMR icon
24
Emerson Electric
EMR
$86.6B
$976K 1.15%
20,400
+16,069
+371% +$765K
DVN icon
25
Devon Energy
DVN
$52.1B
$969K 1.14%
30,284
-13,166
-30% -$540K

Similar funds

Dunvegan Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Dunvegan Associates held 212 positions worth $85.1M, down 3% from $87.7M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Dunvegan Associates withdrew a net $3.87M in Q4 2015, closing 8 positions and reducing 63 holdings. Its most notable exit was VelocityShares Daily Inverse VIX Short Term ETN, an estimated $32K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 19% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Dunvegan Associates opened a new position in Tata Motors Limited worth $1.08M.

  • Dunvegan Associates's largest Q4 2015 buy was Tata Motors Limited: 36,512 shares worth $1.08M.
  • Dunvegan Associates added most to Emerson Electric in Q4 2015, an estimated $765K increase.
  • Dunvegan Associates's biggest Q4 2015 reduction was Enbridge, cutting an estimated $1.07M.
  • Dunvegan Associates fully exited VelocityShares Daily Inverse VIX Short Term ETN in Q4 2015, selling an estimated $32K.
  • Dunvegan Associates's ten largest holdings make up 52% of its $85.1M portfolio in Q4 2015.
  • Dunvegan Associates opened 3 new positions and closed 8 in Q4 2015.
  • Dunvegan Associates's portfolio value fell 3% quarter-over-quarter to $85.1M.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.